Day 1- 2021.03.10: Prepare 6 Corning® BioCoat™ 8-well culture slides à 354632 Corning. Coating with 0,3ml of Poly-D-Lysina (diluted 1/40 with sterile PBS x1) Incubate…
Day 1- 2021.03.08: Prepare 6 Corning® BioCoat™ 8-well culture slides à 354632 Corning. Coating with 0,3ml of Poly-D-Lysina (diluted 1/40 with sterile PBS x1) Incubate…
OBJECTIVES: To detect antibodies against NF155, nodal neurofascins (NF140, NF186) and CNTN1 in Amyotrophic neuralgia patients from Switzerland (ICQ). SAMPLES: For CNTN1: 21-2-0103, 21-2-0105, 21-2-0106,…
OBJECTIVES: To detect antibodies against NF155, nodal neurofascins (NF140, NF186) and CNTN1 in Amyotrophic neuralgia patients from Switzerland (ICQ). SAMPLES: For CNTN1: 21-2-099, 21-2-0101, 21-2,0102,…
OBJECTIVES: There is a problem in the detection of positive samples for NF155/nodal NF without the commercial antibodies. We are going to perform the ICC…
SAMPLES: For NF155, titrate: 19-229; 19-230; neg control, pos control For NF186: 19-200, 19-203; 19-222, neg control, pos control. For these samples, we are going…
Objective and samples: To detect antibodies againts NF155, nodal neurofascin and CNTN1 in CIDP patients for samples 19-196 and 19-197 (ICQ). To confirm negativity in…
Objective: To confirm positivity for NF140/186 in 2 samples, positive for ICC but negative in ELISA. We are going to perform it in non-transfected cells;…
Objective: To test CMT patients for IgG or IgM positivity towards NF140 and NF186. Samples: For NF140 IgG: 101, 113, negative control, positive control. For…
Objective: To test CIDP patients for IgG positivity towards NF140 and 186. Samples: 19-061, 19-163, 19-164, 19-165, 19-166, 19-167, 19-168, 19-169, 19-170, negative control, positive…